Nuclear Factor-ĸB- and Glucocorticoid Receptor α- Mediated Mechanisms in the Regulation of Systemic and Pulmonary Inflammation during Sepsis and Acute Respiratory Distress Syndrome
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that the interaction between nuclear factor-ĸB (NF-ĸB) and glucocorticoid receptor α (GRα) is a key pathogenetic mechanism regulating the progression of systemic and pulmonary inflammation in sepsis and acute respiratory distress syndrome (ARDS), we used an ex vivo model of systemic inflammation. Naïve peripheral blood leukocytes (PBL) were exposed to longitudinal (days 1–10) plasma samples from ARDS patients divided into three groups based on physiological improvement and clinical outcome by days 7–10: improvers, nonimprovers-survivors, and nonimprovers-nonsurvivors. In a separate group of nonimprovers-survivors, we correlated the severity of lung histopathology with the intensity of NF-ĸB and GRα nuclear staining in immunohistochemistry analysis of lung tissue obtained by open lung biopsy. We found that exposure of naïve cells to longitudinal plasma samples led to divergent directions in NF-ĸB and GRα activation that reflected the severity of systemic inflammation. Plasma samples from improvers with declining cytokine levels over time elicited a progressive increase in all measured aspects of glucocorticoid (GC)-induced GRα-mediated activity (p = 0.0001) and a correspondent reduction in NF-ĸB nuclear binding (p = 0.0001) and transcription of TNF-α and IL-1β (regulated, GR α-driven response). In contrast, plasma samples from nonimprovers with sustained elevation in cytokine levels over time elicited only a modest longitudinal increase in GC-GRα-mediated activity (p = 0.04) and a progressive increase in NF-ĸB nuclear binding over time (p = 0.0001) that was most striking in nonsurvivors (dysregulated, NF-ĸ B-driven response). By days 3–5, no overlap was observed between groups for NF-ĸB and GC-GRα nuclear binding. In immunohistochemistry analyses, lung tissues of patients with severe versus mild ARDS had a higher intensity of NF-ĸB nuclear staining (13 ± 1.3 vs. 7 ± 2.9; p = 0.01) and a lower ratio of GRα:NF-ĸB in nuclear staining (0.5 ± 0.2 vs. 1.5 ± 0.2; p = 0.007). In conclusion, we demonstrated that the ability of GC-GRα to downregulate NF-ĸB activation is critical for the resolution of systemic and pulmonary inflammation in ARDS. The findings provide a rationale for the use of prolonged GC treatment in early ARDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overwhelming systemic inflammation that characterizes critical illness is partly driven by an imbalance between hyperactivated inflammatory pathways such as the classical nuclear factor-kappa B (NF-kB) signaling system [6] and the less activated or dysregulated HPAaxis response [7].”
In the citing paper
“Clinical studies in patients with septic shock [79,80] and ARDS [7] have provided evidence of an association between the degree of intracellular glucocorticoid resistance, disease severity, and mortality.”
In the citing paper
“Critical illness is associated with reduced GR-α density and transcription [7,25,82,83]”
In the citing paper
“In experimental ARDS, low-dose glucocorticoid treatment compared with placebo restored GRα number and function with resolution of pulmonary inflammation [7].”
In the citing paper
“In contrast, plasma samples from patients with sustained elevation in inflammatory cytokine levels elicited only modest longitudinal increases in GC-GRα-mediated activity and a progressive increase in NF-kB nuclear binding over time that was most striking in non-survivors (suggesting a dysregulated, NF-kB-driven response).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · cited 1×
“The physiologic function of increases in ACTH and GC levels is to suppress inflammation [”
BackgroundBaeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,646
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Meduri, G. U., Headley, A. S., Golden, E., Carson, S. J., Umberger, R. A., Kelso, T., & Tolley, E. A. (1998) · JAMA · doi:10.1001/jama.280.2.159 · Cited by 1,008
Self-citationAnnane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Self-citationHydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Self-citationParsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000149854.61192.dc · Cited by 723
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
Inflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Self-citationNF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Baeuerle, P. A., & Baichwal, V. R. (1997) · PubMed · Cited by 615
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606
Self-citationKeh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600
Causes and Timing of Death in Patients With ARDS
Stapleton, R. D., Wang, B. M., Hudson, L. D., Rubenfeld, G. D., Caldwell, E. S., & Steinberg, K. P. (2005) · Chest · doi:10.1378/chest.128.2.525 · Cited by 474
Role of NFkappaB in the mortality of sepsis.
Böhrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Männel, D., Böttiger, B. W., Stern, D. M., Waldherr, R., Saeger, H. D., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119648 · Cited by 454
Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone
Hoffman, S. L., Punjabi, N. H., Kumala, S., Moechtar, M. A., Pulungsih, S. P., Rivai, A. R., Rockhill, R. C., Woodward, T. E., & Loedin, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401123100203 · Cited by 319
The Role of Nuclear Factor-κ B in Pulmonary Diseases
Christman, J. W., Sadikot, R. T., & Blackwell, T. S. (2000) · Chest · doi:10.1378/chest.117.5.1482 · Cited by 318
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Lentsch, A. B., Shanley, T. P., Sarma, V, & Ward, P. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119786 · Cited by 296
Schwartz, M. D., Moore, E. E., Moore, F. A., Shenkar, R., Moine, P., Haenel, J. B., & Abraham, E. (1996) · Critical Care Medicine · doi:10.1097/00003246-199608000-00004 · Cited by 287
Corticosteroid Rescue Treatment of Progressive Fibroproliferation in Late ARDS
Umberto Meduri, G., Chinn, A. J., Leeper, K. V., Wunderink, R. G., Tolley, E., Winer-Muram, H. T., Khare, V., & Eltorky, M. (1994) · Chest · doi:10.1378/chest.105.5.1516 · Cited by 277
Self-citationMeduri, G. U., Tolley, E. A., Chrousos, G. P., & Stentz, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2106014 · Cited by 265
Self-citationInfections and the Inflammatory Response in Acute Respiratory Distress Syndrome
Headley, A. S., Meduri, G. U., & Tolley, E. (1997) · Chest · doi:10.1378/chest.111.5.1306 · Cited by 259
Self-citationPerlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/en.132.3.946 · Cited by 257
Melby, J. C., & Spink, W. W. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103772 · Cited by 237
A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids
Wissink, S., van Heerde, E. C., van der Burg, B., & van der Saag, P. T. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0081 · Cited by 225
GAILLARD, R. C., TURNILL, D., SAPPINO, P., & MULLER, A. F. (1990) · Endocrinology · doi:10.1210/endo-127-1-101 · Cited by 220
Amano, Y., Lee, S. W., & Allison, A. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13597-9 · Cited by 209
UMBERTO MEDURI, G., TOLLEY, E. A., CHINN, A., STENTZ, F., & POSTLETHWAITE, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9801107 · Cited by 186
Self-citationMoine, P., McIntyre, R., Schwartz, M. D., Kaneko, D., Shenkar, R., Tulzo, Y. L., Moore, E. E., & Abraham, E. (2000) · Shock · doi:10.1097/00024382-200013020-00001 · Cited by 161
Reincke, M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.151 · Cited by 147
Meduri, G. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122650 · Cited by 129
Self-citationEssential Role of Alveolar Macrophages in Intrapulmonary Activation of NF-κ B
Lentsch, A. B., Czermak, B. J., Bless, N. M., van Rooijen, N., & Ward, P. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3414 · Cited by 123
Carter, A. B., Monick, M. M., & Hunninghake, G. W. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.3.2972 · Cited by 117
Cytokines and the hypothalamic-pituitary-adrenal axis
Hermus, A. R. M. M., & Sweep, F. C. G. J. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90434-m · Cited by 112
Increased nuclear factor κB activation in critically ill patients who die
Paterson, R. L., Galley, H. F., Dhillon, J. K., & Webster, N. R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00022 · Cited by 110
Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB
Ross, S. D., Kron, I. L., Gangemi, J. J., Shockey, K. S., Stoler, M. H., Kern, J. A., Tribble, C. G., & Laubach, V. E. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l528 · Cited by 101
Matsuda, N., Hattori, Y., Jesmin, S., & Gando, S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005926 · Cited by 97
Systemic Inflammation‐Associated Glucocorticoid Resistance and Outcome of ARDS
MEDURI, G. U., & YATES, C. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.004 · Cited by 96
Self-citationMolecular Mechanisms of Immunosuppression and Anti-inflammatory Activities by Glucocorticoids
Didonato, J. A., Saatcioglu, F., & Karin, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s11 · Cited by 79
Groeneveld, J., Raijmakers, P. G. H. M., Hack, E., & Thijis, L. G. (1995) · Cytokine · doi:10.1006/cyto.1995.0089 · Cited by 63
ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME
Steinberg, K. P., & Hudson, L. D. (2000) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70156-8 · Cited by 63
INTERLEUKIN-10 STABILIZES INHIBITORY kB-α IN HUMAN MONOCYTES
Shames, B. D., Selzman, C. H., Meldrum, D. R., Pulido, E. J., Barton, H. A., Meng, X., Harken, A. H., & Mclntyre, R. C. (1998) · Shock · doi:10.1097/00024382-199812000-00002 · Cited by 58
Contribution of cortisol deficiency to septic shock
Briegel, J., Forst, H., Hellinger, H., & Haller, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90575-a · Cited by 54
The fibroproliferative phase of late adult respiratory distress syndrome.
Meduri, G. U., Eltorky, M., & WINER-MURAM, H. T. (1995) · PubMed · Cited by 51
Self-citationMolecular mechanisms of immunosuppression
Baumann, G., Zenke, G., Wenger, R. M., HIESTAND, P. C., Quesniaux, V. F. J., Andersen, E., & Schreier, M. H. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90021-h · Cited by 51
van Woensel, J. B. M., Biezeveld, M. H., Alders, A. M. B., Eerenberg, A. J. M., Endert, E., Hack, E., von Rosenstiel, I. A., & Kuijpers, T. W. (2001) · The Journal of Infectious Diseases · doi:10.1086/324673 · Cited by 47
Romaschin, A. D., Demajo, W., Winton, T. L., D’Costa, M., Chang, G., Rubin, B. B., Gamliel, Z., & Walker, P. M. (1992) · Clinical Biochemistry · doi:10.1016/0009-9120(92)80046-j · Cited by 38
Nys, M., Deby-Dupont, G. P., Habraken, Y., Legrand-Poels, S., Kohnen, S. L., Ledoux, D., Canivet, J.-L., Damas, P., & Lamy, M. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.07.001 · Cited by 28
Poppers, D. M., Schwenger, P., & Vilček, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002806200 · Cited by 26
Immunoregulatory Genes and Immunosuppression by Glucocorticoids
Auphan‐Anezin, N., DiDonato, J. A., Helmberg, A., Rosette, C., & Karin, M. (1997) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-60682-3_8 · Cited by 21
Neuroendocrine Regulation of the Immune Process
Chrousos, G. P., Bamberger, C. M., & Mastorakos, G. P. (1998) · CRC Press eBooks · doi:10.1201/9781420048193.ch2 · Cited by 20
Self-citationMeduri, G. U., Golden, E. B., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M. M., & Umberger, R. A. (2005) · CHEST Journal · doi:10.1378/chest.128.4_meetingabstracts.129s-b · Cited by 12
Self-citationThe Early Inflammatory Response in Acute Respiratory Distress Syndrome (ARDS)
Hirani, N., & Donnelly, S. C. (1998) · Springer eBooks · doi:10.1007/978-1-4419-8634-4_19 · Cited by 2
Research works printed but not linked: 4
- 10.1210%2Fer.17.3.245 · DOI · Paper page
- 10.1210%2Fme.12.3.355 · DOI
- 10.1378%2Fchest.100.6.1619 · DOI · Paper page
- 10.1016%2FS0065-2776%2808%2960742-7 · DOI · Paper page
Cited by
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Hydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
“(69) demonstrated reduced nuclear translocation of the GR complex in patients with fatal ARDS, despite adequate cytoplasmic (and serum) levels of cortisol.”
BackgroundSelf-citationMethylprednisolone Infusion in Early Severe ARDS
Meduri, G. U., Golden, E., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M., & Umberger, R. (2007) · Chest · doi:10.1378/chest.06-2100 · Cited by 787
Self-citationHas Mortality from Acute Respiratory Distress Syndrome Decreased over Time?: A Systematic Review
Phua, J., Badia, J. R., Adhikari, N. K. J., Friedrich, J. O., Fowler, R. A., Singh, J. M., Scales, D. C., Stather, D. R., Li, A., Jones, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-722oc · Cited by 727
Metadata
- Authors
- Meduri, G. U., Muthiah, M. P., Carratù, P., Eltorky, M., & Chrousos, G. P.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 12
- Issue
- 6
- Pages
- 321-338
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2012983034
- Cited by
- 167
- References
- 64
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 12
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- NF-κB, glucocorticoid receptor alpha, sepsis, acute respiratory distress syndrome, systemic inflammation, lung inflammation, glucocorticoid resistance, cytokine regulation, TNF-α, IL-1β, peripheral blood leukocytes, plasma exposure, lung histopathology, ARDS mortality, glucocorticoid therapy, transcriptional regulation
- MeSH terms
- Adult, Female, Glucocorticoids, Humans, Inflammation, Leukocytes, Lung, Male, Methylprednisolone, Middle Aged, Receptors, Glucocorticoid, Respiratory Distress Syndrome, Cytokines, NF-kappa B, Sepsis, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.